Search Results: N10-008 PrüfungGuide, CompTIA N10-008 Zertifikat - CompTIA Network+ Certification Exam 🔨 Suchen Sie einfach auf 【 www.itzert.com 】 nach kostenloser Download von ➽ N10-008 🢪 ❣N10-008 Deutsch Prüfung
Partnership brings Iterative Scopes’ AI Recruitment technology to One GI® Excerpt from the Press Release: CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with One GI®, a gastroenterology management services organization (MSO), to bring its AI Recruitment (AIR) technology to One GI’s clinical research. Initially, One…
Read More
Excerpt from the Press Release: The Ontario Brain Institute (OBI) has released a new set of clinical imaging modalities from a Province of Ontario Neurodevelopmental Network (POND) study for cohort of over 600 children and youth, some diagnosed with various neurodevelopmental disorders and others typically developing.This cleaned, standardized, and curated dataset is available for download on Brain-CODE, OBI’s neuroinformatics and analytics platform.…
Read More
– Disparities, Such as Access to Healthcare, Comorbidities and Differences in TNBC Disease Biology Typically Drive Worse Clinical Outcomes in Black Women Excerpt from the Press Release: FOSTER CITY, Calif.–(BUSINESS WIRE)–Dec. 10, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from the Phase 3 ASCENT study evaluating Trodelvy® (sacituzumab govitecan-hziy) in relapsed or refractory metastatic triple-negative breast…
Read More
– Enrollment Stopped Early for Efficacy – Excerpt from the Press Release: EXTON, Pa., May 17, 2022 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera,” “we,” and “our”) (Nasdaq: IDRA) today shared positive interim results from Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands, regarding its investigator-sponsored trial, INTRIM 1, involving tilsotolimod, Idera’s synthetic Toll-like receptor 9…
Read MorePartnering With The Best Technology and Services Providers Contract Research Organizations Alimentiv URL: https://www.alimentiv.com Phone: (604) 676 5900 Alimentiv is a GI-focused Contract Research Organization (CRO) that provides a broad range of clinical research services to pharmaceutical and biotechnology companies, and academic investigators. Alimentiv offers end-to-end services and trial management for full-service clinical trial studies…
Read More
Excerpt from the Article: The East Coast Institute for Clinical Research (ECIR) is a site network with five offices throughout the Northeast Florida and Georgia conducting clinical trials across several therapeutic areas. Rebecca Goldfaden, VP of clinical operations for ECIR, has worked with more than 80 sponsor companies during her career in clinical research. She…
Read More
On September 13th we began our virtual exhibition at the SCDM 2020 meeting. What a fantastic event this year! Despite having to go virtual, the SCDM meeting organizers and AV partner were able to produce an outstanding meeting for the attendees and vendors with plenty of opportunities to network, present and of course, learn! Congratulations…
Read More
Excerpt from the Press Release: Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health, have shown that a triple drug combination – of irinotecan, cetuximab, and vemurafenib – is a more powerful tumor fighter and keeps people with metastatic…
Read More
Meet in person with Christopher Kata during CPHI in Frankfurt, on November 1st to 3rd. If you’re attending be sure to reach out to Christopher to schedule a one on meeting! Each year CPHI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global…
Read More
Excerpt from the Press Release: BOSTON and LAUSANNE, Switzerland, June 1, 2021 /PRNewswire/ — SOPHiA GENETICS, the creator of a global data-sharing network that advances data-driven medicine, today released SOPHiA DDM™ for Blood Cancers, novel blood cancer testing solutions across the entire workflow from setup, genomic testing, and in-house advanced analytics. The solutions target the most relevant DNA variants and RNA fusion genes…
Read More